{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:32:50Z","timestamp":1791192770039,"version":"4.1.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"FAPESC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013379","name":"Instituto C\u00e9rebro e Mente","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013379","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.lfs.2016.06.027","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T12:04:42Z","timestamp":1467201882000},"page":"121-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Neurochemical correlation between major depressive disorder and neurodegenerative diseases"],"prefix":"10.1016","volume":"158","author":[{"given":"Gislaine Z.","family":"R\u00e9us","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Titus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena M.","family":"Abelaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita","family":"Tuon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Budni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.06.027_bb0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.amepre.2007.04.035","article-title":"Community-based treatment of late life depression: an expert panel-informed literature review","volume":"33","author":"Frederick","year":"2007","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0010","article-title":"Treating depression in older adults: challenges to implementing the recommendations of an expert panel","volume":"5","author":"Snowden","year":"2008","journal-title":"Prev. Chronic Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.lfs.2016.06.027_bb0015","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC) mental illness surveillance among adults in the United States","volume":"60","author":"Reeves","year":"2011","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.lfs.2016.06.027_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2009.04.1232","article-title":"Subtypes of depression among patients with Alzheimer's disease and other dementias","volume":"6","author":"Castilla-Puentes","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.lfs.2016.06.027_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systemic review of prevalence studies of depression in Parkinson's disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2016.06.027_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archneur.64.1.116","article-title":"Specific psychiatric manifestations among preclinical Huntington disease mutation carriers","volume":"64","author":"Marshall","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/17482968.2011.556744","article-title":"Prevalence of major depression in ALS: comparison of a semi-structured interview and four-self report measures","volume":"12","author":"Ferentinos","year":"2011","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.lfs.2016.06.027_bb0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/jnp.13.2.187","article-title":"Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease","volume":"13","author":"Slaughter","year":"2001","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0045","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.genhosppsych.2007.11.005","article-title":"Behavioral problems in Huntington's disease using the problem behaviors assessment","volume":"30","author":"Kingma","year":"2008","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","article-title":"Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease","volume":"24","author":"Thompson","year":"2012","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/gps.1858","article-title":"Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study","volume":"23","author":"Steinberg","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0065","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1176\/jnp.9.4.556","article-title":"Major and minor depression in Alzheimer's disease: prevalence and impact","volume":"9","author":"Lyketsos","year":"1997","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0070","series-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde, Allgemeine Zeitschrift f\u00fcr Psychiatrie und Psychisch-Gerichtliche Medizine","first-page":"146","volume":"64","author":"Alzheimer","year":"1907"},{"key":"10.1016\/j.lfs.2016.06.027_bb0075","first-page":"137","article-title":"Examining the relationship between head trauma and neurodegenerative disease: a review of epidemiology, pathology and neuroimaging techniques","volume":"4","author":"Sundman","year":"2014","journal-title":"J. Alzheimers Dis. Parkinsonism"},{"key":"10.1016\/j.lfs.2016.06.027_bb0080","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2016.06.027_bb0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.lfs.2016.06.027_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00429-009-0232-6","article-title":"APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis","volume":"214","author":"Crews","year":"2010","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.lfs.2016.06.027_bb0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hipo.1993.4500030727","article-title":"Entorhinal-hippocampal interaction in amnestic disorders","volume":"3","author":"Braak","year":"1993","journal-title":"Hippocampus"},{"key":"10.1016\/j.lfs.2016.06.027_bb0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/gps.4126","article-title":"Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome","volume":"30","author":"Varon","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0115","doi-asserted-by":"crossref","first-page":"11414","DOI":"10.1523\/JNEUROSCI.2127-10.2010","article-title":"Microglial receptor for advanced glycation end product dependent signal pathway drives beta-amyloid-induced synaptic depression and long term depression impairment in entorhinal cortex","volume":"30","author":"Origlia","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrn1495","article-title":"Strategies for disease modification in Alzheimer's disease","volume":"5","author":"Citron","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5114\/fn.2014.45562","article-title":"A critical analysis of the \u2018amyloid cascade hypothesis\u2019","volume":"52","author":"Armstrong","year":"2014","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0135","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2016.06.027_bb0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid \u03b2 oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis","volume":"129","author":"Viola","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0145","first-page":"882","article-title":"Risk factors for dementia and Alzheimer\u2019 s disease-findings from a community-based cohort study in Stockholm, Sweden","volume":"26","author":"Qiu","year":"2005","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.lfs.2016.06.027_bb0150","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-159007","article-title":"Lifetime history of depression predicts increased amyloid-\u03b2 accumulation in patients with mild cognitive impairment","author":"Chung","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2016.06.027_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16210","article-title":"The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model","volume":"16","author":"Bond","year":"2012","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.lfs.2016.06.027_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ageing\/afs165","article-title":"Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model","volume":"42","author":"Hyde","year":"2013","journal-title":"Age Ageing"},{"key":"10.1016\/j.lfs.2016.06.027_bb0165","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/gps.4192","article-title":"Examining the association between late-life depressive symptoms, cognitive function, and brain volumes in the context of cognitive reserve","volume":"30","author":"O'Shea","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0170","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/gps.3909","article-title":"Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease","volume":"28","author":"Van der Mussele","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0175","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/0004-282X20140108","article-title":"Impaired cognition in depression and Alzheimer (AD): a gradient from depression to depression in AD","volume":"72","author":"Araujo","year":"2014","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.lfs.2016.06.027_bb0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gps.2317","article-title":"Associations between stroke risk and cognition in normal aging and Alzheimer's disease with and without depression","volume":"25","author":"Bangen","year":"2010","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0185","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.jagp.2013.11.004","article-title":"Hippocampus atrophy and the longitudinal course of late-life depression","volume":"22","author":"Taylor","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0190","article-title":"Impairments in neurogenesis are not tightly linked to depressive behavior in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Iascone","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.06.027_bb0195","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/jnnp-2013-307110","article-title":"Alzheimer's disease neuroimaging initiative. Structural brain changes associated with depressive symptoms in the elderly with Alzheimer's disease","volume":"85","author":"Lebedeva","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainresbull.2014.09.003","article-title":"Neuropsychiatric symptoms in dementia-a role for neuroinflammation?","volume":"108","author":"Holmgren","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2016.06.027_bb0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.10.022","article-title":"Depression and Alzheimer's disease: neurobiological links and common pharmacological targets","volume":"626","author":"Caraci","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/gps.3973","article-title":"Increased frequency of cluster of differentiation 14 (CD14+) monocytes expressing interleukin 1 beta (IL-1\u03b2) in Alzheimer's disease patients and intermediate levels in late-onset depression patients","volume":"29","author":"Torres","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0215","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.3949\/ccjm.78.s1.08","article-title":"Inflammatory signaling in Alzheimer disease and depression","volume":"1","author":"Barber","year":"2011","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4088\/JCP.10m06766","article-title":"Metabolism of amyloid-\u03b2 protein may be affected in depression","volume":"73","author":"Baba","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0225","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mp.2012.168","article-title":"Amyloid-\u03b2 oligomers link depressive-like behavior and cognitive deficits in mice","volume":"18","author":"Ledo","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0230","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1176\/appi.ajp.2011.11081153","article-title":"Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder","volume":"169","author":"Pomara","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pnpbp.2013.12.001","article-title":"GSK3\u03b2, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression","volume":"50","author":"Pl\u00e1ten\u00edk","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0240","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/15622975.2010.551408","article-title":"Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?","volume":"12","author":"Diniz","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0245","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/geronb\/gbu096","article-title":"Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression","volume":"69","author":"Diniz","year":"2014","journal-title":"J. Gerontol. B. Psychol. Sci. Soc. Sci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1744-9081-10-8","article-title":"Comparison of alterations in cerebral hemoglobin oxygenation in late life depression and Alzheimer's disease as assessed by near-infrared spectroscopy","volume":"10","author":"Kito","year":"2014","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.lfs.2016.06.027_bb0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jagp.2014.05.001","article-title":"Depression and synaptic zinc regulation in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia","volume":"23","author":"Whitfield","year":"2015","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0260","first-page":"3908","article-title":"The prevalence of Parkinson's disease continues to rise after 80years of age: a cross-sectional study of Chinese veterans","volume":"18","author":"Zou","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0265","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease - first of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0270","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson's disease - second of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fnana.2014.00152","article-title":"Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update","volume":"8","author":"Brichta","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.lfs.2016.06.027_bb0280","article-title":"Parkinson's disease beyond 20years","author":"Cilia","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0285","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12035-012-8369-3","article-title":"The central theme of Parkinson's disease: \u03b1-synuclein","volume":"47","author":"Ozansoy","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0290","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.annepidem.2013.12.010","article-title":"Psychiatric diseases predated the occurrence of Parkinson disease: a retrospective cohort study","volume":"24","author":"Lin","year":"2014","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1326-8-44","article-title":"rAAV2\/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration","volume":"8","author":"Oliveras-Salv\u00e1","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.lfs.2016.06.027_bb0300","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson's disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbadis.2009.08.013","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"1802","author":"Winklhofer","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2016.06.027_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12312","article-title":"Parkinson's disease as a result of aging","author":"Rodriguez","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.lfs.2016.06.027_bb0315","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0320","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.metabol.2014.10.030","article-title":"Biomarkers of Parkinson's disease: present and future","volume":"64","author":"Miller","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2016.06.027_bb0325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1353-8020(00)00038-9","article-title":"Dopamine agonists: the treatment for Parkinson's disease in the XXI century?","volume":"7","author":"Lled\u00f3","year":"2000","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.lfs.2016.06.027_bb0330","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mds.26102","article-title":"The medical treatment of Parkinson disease from James Parkinson to George Cotzias","volume":"30","author":"S. Fahn","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2016.06.027_bb0335","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ncl.2014.09.009","article-title":"Treatment strategies in early and advanced Parkinson disease","volume":"33","author":"Ossig","year":"2015","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.lfs.2016.06.027_bb0340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/2045125312470130","article-title":"Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review","volume":"3","author":"Poletti","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0345","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fneur.2012.00088","article-title":"Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management","volume":"3","author":"Meireles","year":"2012","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0350","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","article-title":"Prevalence, etiology, and treatment of depression in Parkinson's disease","volume":"54","author":"McDonald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0355","first-page":"157","article-title":"Anxious and depressive symptoms in Parkinson's disease: the French cross-sectional DoPaMiP study","volume":"2011","author":"Negre-Pages","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2016.06.027_bb0360","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.parkreldis.2014.03.020","article-title":"Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease","volume":"20","author":"Sagna","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.lfs.2016.06.027_bb0365","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/01.wnl.0000268695.63392.10","article-title":"The impact of depressive symptoms in early Parkinson disease","volume":"69","author":"Ravina","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2016.06.027_bb0370","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrneurol.2010.49","article-title":"Parkinson disease: depression and anxiety in parkinson disease","volume":"6","author":"Mart\u00ednez-Mart\u00edn","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0375","first-page":"441","article-title":"Mild cognitive impairment in Parkinson's disease","volume":"102","author":"Goldman","year":"2011","journal-title":"Minerva Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052285","article-title":"\u03b1-Synuclein and anti-\u03b1-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls","volume":"7","author":"Smith","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.06.027_bb0385","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/msj.20094","article-title":"Physical exercise and depression","volume":"76","author":"Aan het Rot","year":"2009","journal-title":"Mt Sinai J. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0390","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/mds.10643","article-title":"What is the evidence that ecstasy (MDMA) can cause Parkinson's disease?","volume":"18","author":"Kish","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2016.06.027_bb0395","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00415-010-5666-5","article-title":"Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter","volume":"258","author":"Strecker","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0400","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fneur.2014.00078","article-title":"Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations","volume":"5","author":"Carta","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0405","first-page":"113","article-title":"Advances in non-dopaminergic treatments for Parkinson's disease","volume":"8","author":"Styte","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0410","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2016.06.027_bb0415","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11940-013-0281-2","article-title":"Treatment of psychosis and dementia in Parkinson's disease","volume":"16","author":"Goldman","year":"2014","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0420","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2016.06.027_bb0425","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1016\/S0893-133X(99)00046-9","article-title":"The role of serotonin in antipsychotic drug action","volume":"21","author":"Meltzer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.lfs.2016.06.027_bb0430","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1474-4422(10)70287-8","article-title":"Accurate prevalence and uptake of testing for Huntington's disease","volume":"9","author":"Morrison","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2014.12.013","article-title":"Update on Huntington's disease: advances in care and emerging therapeutic options","author":"Zielonka","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.lfs.2016.06.027_bb0440","first-page":"359","article-title":"Huntington's disease: pathogenesis, diagnosis and treatment","volume":"19","author":"Purdon","year":"1994","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0445","first-page":"217","article-title":"Huntington's disease: the past, present, and future search for disease modifiers","volume":"86","author":"Clabough","year":"2013","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0450","series-title":"The Huntington's Disease Collaborative Research Group Cell","first-page":"971","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993"},{"key":"10.1016\/j.lfs.2016.06.027_bb0455","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0460","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gene.2014.11.022","article-title":"Huntington's disease: an update of therapeutic strategies","volume":"556","author":"Kumar","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.lfs.2016.06.027_bb0465","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fnbeh.2014.00135","article-title":"Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms","volume":"8","author":"Pla","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0470","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2190\/OM.65.4.e","article-title":"Accounts of suicidality in the Huntington disease community","volume":"65","author":"Halpin","year":"2012","journal-title":"Omega (Westport)"},{"key":"10.1016\/j.lfs.2016.06.027_bb0475","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.psym.2011.12.010","article-title":"Psychiatric disorders in Huntington's disease: a 2-year follow-up study","volume":"53","author":"Reedeker","year":"2012","journal-title":"Psychosomatics"},{"key":"10.1016\/j.lfs.2016.06.027_bb0480","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1017\/S003329171300247X","article-title":"The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study","volume":"44","author":"Sprengelmeyer","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0485","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.11.063","article-title":"Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation","volume":"507","author":"Orvoen","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2016.06.027_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.genhosppsych.2013.01.015","article-title":"Rapid improvement of depression and psychotic symptoms in Huntington's disease: a retrospective chart review of seven patients treated with electroconvulsive therapy","volume":"35","author":"Cusin","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0495","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1176\/appi.ajp.2009.09070973","article-title":"Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder","volume":"167","author":"Perlis","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0500","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1503\/jpn.100067","article-title":"Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography","volume":"36","author":"Krogias","year":"2011","journal-title":"Psychiatry Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022133","article-title":"Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression","volume":"6","author":"Renoir","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.06.027_bb0510","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0515","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/YIC.0b013e3283348018","article-title":"Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR","volume":"25","author":"Holl","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0520","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2990.2005.00686.x","article-title":"Return of the cycad hypothesis: does the amyotrophic lateral sclerosis\/parkinsonism dementia complex (ALS\/PDC) of Guam have new implications for global health?","volume":"31","author":"Ince","year":"2005","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0525","first-page":"w14054","article-title":"Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis","volume":"145","author":"Laferriere","year":"2015","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.lfs.2016.06.027_bb0530","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2016.06.027_bb0535","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2014-308946","article-title":"The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey","author":"Turner","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0540","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S1474-4422(07)70265-X","article-title":"Cognitive impairment in amyotrophic lateral sclerosis","volume":"6","author":"Phukan","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0545","first-page":"19","article-title":"Neural substrate of cognitive theory of mind impairment in amyotrophic lateral sclerosis","volume":"65C","author":"Carluer","year":"2014","journal-title":"Cortex"},{"key":"10.1016\/j.lfs.2016.06.027_bb0550","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrneurol.2011.152","article-title":"Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis","volume":"7","author":"Ferraiuolo","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0555","series-title":"Amyotroph Side Scler Frontotemporal Degeneration","article-title":"Depression and wish to die in a multicenter cohort of ALS patients","author":"Rabkin","year":"2014"},{"key":"10.1016\/j.lfs.2016.06.027_bb0560","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00023210-200721040-00003","article-title":"Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management","volume":"21","author":"Kurt","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.lfs.2016.06.027_bb0565","first-page":"115","article-title":"Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study","volume":"28","author":"Pizzimenti","year":"2013","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0570","series-title":"Programme on Ageing: The Ageing of the World's Population","author":"United Nations","year":"2009"},{"key":"10.1016\/j.lfs.2016.06.027_bb0575","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fncel.2014.00373","article-title":"De-regulation of gene expression and alternative splicing affects distinct cellular pathways in the aging hippocampus","volume":"8","author":"Stilling","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0580","series-title":"Envelhecimento: um processomultifatorial, Psicologia em estudo","first-page":"3","volume":"14","author":"Santos","year":"2009"},{"key":"10.1016\/j.lfs.2016.06.027_bb0585","first-page":"00049-2","article-title":"Comparison of mice with accelerated aging caused by distinct mechanisms","volume":"S0531-5565","author":"Gurkar","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0590","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.tins.2006.10.002","article-title":"Neurocognitive aging: prior memories hinder new hippocampal encoding","volume":"29","author":"Wilson","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0595","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fgene.2014.00155","article-title":"Longevity pathways and memory aging","volume":"5","author":"Gkikas","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.lfs.2016.06.027_bb0600","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13195-014-0085-y","article-title":"Quantitative neuropathological assessment to investigate cerebral multi-morbidity","volume":"6","author":"Attems","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.lfs.2016.06.027_bb0605","doi-asserted-by":"crossref","first-page":"29","DOI":"10.31887\/DCNS.2013.15.1\/kjellinger","article-title":"Neuropathological approaches to cerebral aging and neuroplasticity","volume":"15","author":"Jellinger","year":"2013","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0610","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.neubiorev.2006.07.001","article-title":"Differential aging of the brain: patterns, cognitive correlates and modifiers","volume":"30","author":"Raz","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.lfs.2016.06.027_bb0615","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.278.5337.412","article-title":"Life and death of neurons in the aging brain","volume":"278","author":"Morrison","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.lfs.2016.06.027_bb0620","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fgene.2014.00419","article-title":"Phospholipase A2 - nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? Insights from a snail model system of neuronal aging and age-associated memory impairment","volume":"5","author":"Hermann","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.lfs.2016.06.027_bb0625","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3233\/JAD-2012-121078","article-title":"Exercise-induced noradrenergic activation enhances memory consolidation in both normal aging and patients with amnestic mild cognitive impairment","volume":"32","author":"Segal","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2016.06.027_bb0630","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.arr.2009.03.004","article-title":"The role of epigenetics in aging and age-related diseases","volume":"8","author":"Calvanese","year":"2009","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.lfs.2016.06.027_bb0635","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molmed.2009.11.003","article-title":"Epigenetics: molecular mechanisms and implications for disease","volume":"16","author":"Handel","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0640","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.3390\/ijms140917897","article-title":"Oxidative stress in aging\u2013matters of the heart and mind","volume":"14","author":"Venkataraman","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0645","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2298\/SARH08S2158D","article-title":"Oxidative stress in human diseases","volume":"2","author":"Djordjevi\u0107","year":"2008","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.lfs.2016.06.027_bb0650","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuint.2010.12.016","article-title":"Mitochondrial dysfunction in brain aging: role of oxidative stress and cardiolipin","volume":"58","author":"Paradies","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2016.06.027_bb0655","doi-asserted-by":"crossref","first-page":"856273","DOI":"10.1155\/2014\/856273","article-title":"New insights into the chemical and biochemical basis of the \u201cyang-invigorating\u201d action of Chinese yang-tonic herbs","volume":"2014","author":"Chen","year":"2014","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0660","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0665","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/157488711796575577","article-title":"Neuroinflammation and ageing: current theories and an overview of the data","volume":"6","author":"Pizza","year":"2011","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.lfs.2016.06.027_bb0670","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnmol.2014.00104","article-title":"Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration","volume":"7","author":"Figueiredo-Pereira","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0675","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1741-7015-9-98","article-title":"Epigenetic regulation of caloric restriction in aging","volume":"9","author":"Li","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0680","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10522-014-9516-1","article-title":"Perfusion deficits, inflammation and aging precipitate depressive behavior","volume":"15","author":"Popa-Wagner","year":"2014","journal-title":"Biogerontology"},{"key":"10.1016\/j.lfs.2016.06.027_bb0685","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/7854_2011_158","article-title":"Successful cognitive aging","volume":"10","author":"Depp","year":"2012","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0690","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1176\/ps.50.9.1167","article-title":"Depression and aging: a look to the future","volume":"50","author":"Reynolds","year":"1999","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.lfs.2016.06.027_bb0695","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jagp.2013.01.040","article-title":"Anticipated brain molecular aging in major depression","volume":"21","author":"Douillard-Guilloux","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0700","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jagp.2013.01.053","article-title":"The age-by-disease interaction hypothesis of late-life depression","volume":"21","author":"McKinney","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0705","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0749-0690(18)30476-2","article-title":"Epidemiology of geriatric affective disorders","volume":"8","author":"Koenig","year":"1992","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0710","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1532-5415.2005.53202.x","article-title":"The course of functional decline in older people with persistently elevated depressive symptoms: longitudinal findings from the Cardiovascular Health Study","volume":"53","author":"Lenze","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.lfs.2016.06.027_bb0715","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/archpsyc.63.2.130","article-title":"Perspectives on depression, mild cognitive impairment, and cognitive decline","volume":"63","author":"Steffens","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0720","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.clinpsy.032408.153621","article-title":"Depression in older adults","volume":"5","author":"Fiske","year":"2009","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0725","first-page":"210-1","article-title":"Depression and the aging brain","volume":"95","author":"Stanton","year":"2012","journal-title":"Med. Health R. I."},{"key":"10.1016\/j.lfs.2016.06.027_bb0730","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.pathmechdis.2.010506.092044","article-title":"The aging brain","volume":"3","author":"Yankner","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0735","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pneurobio.2010.11.006","article-title":"Between destiny and disease: genetics and molecular pathways of human central nervous system aging","volume":"93","author":"Glorioso","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0740","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11920-006-0079-y","article-title":"Course and outcomes of depression in the elderly","volume":"8","author":"Kohn","year":"2006","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.lfs.2016.06.027_bb0745","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nature02661","article-title":"Gene regulation and DNA damage in the ageing human brain","volume":"429","author":"Lu","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2016.06.027_bb0750","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.biopsych.2004.10.034","article-title":"Molecular aging in human prefrontal cortex is selective and continuous throughout adult life","volume":"57","author":"Erraji-Benchekroun","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0755","doi-asserted-by":"crossref","first-page":"12698-03","DOI":"10.1073\/pnas.0914257107","article-title":"Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways","volume":"107","author":"Miller","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2016.06.027_bb0760","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-3806(02)00540-0","article-title":"BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex","volume":"139","author":"Webster","year":"2002","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.lfs.2016.06.027_bb0765","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.mp.4001637","article-title":"BDNF in schizophrenia, depression and corresponding animal models","volume":"10","author":"Angelucci","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0770","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/mp.2011.113","article-title":"Molecular evidence for BDNF- and GABA related dysfunctions in the amygdala of female subjects with major depression","volume":"17","author":"Guilloux","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0775","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11064-012-0708-2","article-title":"Neuroinflammation and synaptic loss","volume":"37","author":"Rao","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2016.06.027_bb0780","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.neurobiolaging.2005.03.010","article-title":"Peripheral infection and aging interact to impair hippocampal memory consolidation","volume":"27","author":"Barrientos","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.lfs.2016.06.027_bb0785","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbi.2007.08.014","article-title":"Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system","volume":"22","author":"Chen","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2016.06.027_bb0790","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.arr.2013.05.008","article-title":"Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction","volume":"12","author":"Sama","year":"2013","journal-title":"Aging Res. Rev."},{"key":"10.1016\/j.lfs.2016.06.027_bb0795","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1113\/expphysiol.2005.030734","article-title":"Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system","volume":"290","author":"Pickering","year":"2005","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.lfs.2016.06.027_bb0800","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S1734-1140(09)70173-2","article-title":"Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood","volume":"61","author":"Kubera","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2016.06.027_bb0805","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2014.10.022","article-title":"Ketamine ameliorates depressive-like behaviors and immune alterations in adult rats following maternal deprivation","volume":"584","author":"R\u00e9us","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2016.06.027_bb0810","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0018-506X(02)00016-8","article-title":"Neuroendocrine aspects of hypercortisolism in major depression","volume":"43","author":"Parker","year":"2003","journal-title":"Horm. Behav."},{"key":"10.1016\/j.lfs.2016.06.027_bb0815","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1471-4159.2008.05642.x","article-title":"Age-dependent effects of chronic stress on brain plasticity and depressive behavior","volume":"107","author":"Toth","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2016.06.027_bb0820","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/hbm.20801","article-title":"Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies","volume":"30","author":"Koolschijn","year":"2009","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.lfs.2016.06.027_bb0825","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.psc.2011.02.001","article-title":"Structural neuroimaging of geriatric depression","volume":"34","author":"Benjamin","year":"2011","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.lfs.2016.06.027_bb0830","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1017\/S0033291707000128","article-title":"Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms","volume":"37","author":"Taylor","year":"2007","journal-title":"Psychol. Med."},{"key":"10.1016\/j.lfs.2016.06.027_bb0835","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-3223(00)00829-5","article-title":"Hippocampal volume in geriatric depression","volume":"48","author":"Steffens","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0840","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1192\/bjp.184.6.488","article-title":"Hippocampal volume change in depression: late- and early onset illness compared","volume":"184","author":"Lloyd","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0845","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0165-0173(99)00017-X","article-title":"Involvement of hippocampal synaptic plasticity in age-related memory decline","volume":"30","author":"Foster","year":"1999","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.lfs.2016.06.027_bb0850","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fnbeh.2014.00136","article-title":"Learning and memory impairments in a neuroendocrine mouse model of anxiety\/depression","volume":"8","author":"Darcet","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.027_bb0855","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jad.2013.09.012","article-title":"Cognitive dysfunction in unipolar depression: implications for treatment","volume":"152\u2013154","author":"Trivedi","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.lfs.2016.06.027_bb0860","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/hbm.20426","article-title":"A meta-analytic study of changes in brain activation in depression","volume":"29","author":"Fitzgerald","year":"2008","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.lfs.2016.06.027_bb0865","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.psc.2011.02.010","article-title":"Functional neuroimaging in geriatric depression","volume":"34","author":"Gunning","year":"2009","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.lfs.2016.06.027_bb0870","first-page":"341","article-title":"Geriatric depression: The use of antidepressants in the elderly","volume":"53","author":"Wiese","year":"2011","journal-title":"BC. Med. J."},{"key":"10.1016\/j.lfs.2016.06.027_bb0875","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2165\/00002512-200825100-00003","article-title":"Use of antidepressants in late-life depression","volume":"25","author":"Rajji","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.lfs.2016.06.027_bb0880","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/JGP.0b013e3181ec8085","article-title":"Continuing treatment of depression in the elderly: a systematic review and meta-analysis of double-blinded randomized controlled trials with antidepressants","volume":"19","author":"Kok","year":"2011","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.027_bb0885","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/gerona\/58.3.M249","article-title":"Depression in late life: review and commentary","volume":"58A","author":"Blazer","year":"2003","journal-title":"Gerontol. Med. Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516303836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516303836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T10:51:28Z","timestamp":1656759088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516303836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":177,"alternative-id":["S0024320516303836"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.06.027","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurochemical correlation between major depressive disorder and neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}